BOSTON, MA—A percutaneous mechanical thrombectomy device for pulmonary embolism (PE) improves hemodynamics and heart rate while patients are still in the procedure room, according to outcomes from the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Large-bore mechanical thrombectomy for pulmonary ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

NEW ORLEANS -- Large-bore mechanical thrombectomy for high-risk pulmonary embolism (PE) was associated with fewer major adverse outcomes than other approaches, the FLAME study showed. Clot removal ...

The use of mechanical thrombectomy (MT) was associated with reduced major adverse events in the short term and improved quality of life in the long term for pulmonary embolism (PE) patients with ...

Please provide your email address to receive an email when new articles are posted on . Catheter-directed thrombolysis was linked to less major bleeding than mechanical thrombectomy in patients with ...

Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Symphony(R) Thrombectomy System to treat pulmonary embolism (PE), a life-threatening condition ...

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and effectiveness results were ...

Thrombolytics, intravenous or catheter-directed, can be an effective treatment option for acute pulmonary embolism (PE) but pose a hazard to the many patients who have risk factors for serious ...

New research from the FLASH registry (ClinicalTrials.gov identifier: NCT03761173) shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism.

Endovascular Engineering (E2) has completed enrolment of subjects in the pivotal cohort of its ENGULF trial, involving the Hēlo PE Thrombectomy System. The investigational device exemption study was ...